Literature DB >> 35389442

Low von Willebrand factor phenotype: the enigma continues.

David Lillicrap1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35389442      PMCID： PMC8990378          DOI： 10.1182/blood.2021013541

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study.

Authors:  Paula D James; Colleen Notley; Carol Hegadorn; Jayne Leggo; Angie Tuttle; Shawn Tinlin; Christine Brown; Chandler Andrews; Andrea Labelle; Yvette Chirinian; Lee O'Brien; Maha Othman; Georges Rivard; Dilys Rapson; Christine Hough; David Lillicrap
Journal:  Blood       Date:  2007-01-01       Impact factor: 22.113

2.  The prevalence of symptomatic von Willebrand disease in primary care practice.

Authors:  M Bowman; W M Hopman; D Rapson; D Lillicrap; P James
Journal:  J Thromb Haemost       Date:  2009-10-23       Impact factor: 5.824

3.  Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels.

Authors:  Michelle Lavin; Sonia Aguila; Sonja Schneppenheim; Niall Dalton; Kenneth L Jones; Jamie M O'Sullivan; Niamh M O'Connell; Kevin Ryan; Barry White; Mary Byrne; Marie Rafferty; Mairead M Doyle; Margaret Nolan; Roger J S Preston; Ulrich Budde; Paula James; Jorge Di Paola; James S O'Donnell
Journal:  Blood       Date:  2017-09-15       Impact factor: 22.113

4.  Variation at the von Willebrand factor (vWF) gene locus is associated with plasma vWF:Ag levels: identification of three novel single nucleotide polymorphisms in the vWF gene promoter.

Authors:  A M Keightley; Y M Lam; J N Brady; C L Cameron; D Lillicrap
Journal:  Blood       Date:  1999-06-15       Impact factor: 22.113

5.  Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD).

Authors:  Anne Goodeve; Jeroen Eikenboom; Giancarlo Castaman; Francesco Rodeghiero; Augusto B Federici; Javier Batlle; Dominique Meyer; Claudine Mazurier; Jenny Goudemand; Reinhard Schneppenheim; Ulrich Budde; Jorgen Ingerslev; David Habart; Zdena Vorlova; Lars Holmberg; Stefan Lethagen; John Pasi; Frank Hill; Mohammad Hashemi Soteh; Luciano Baronciani; Christer Hallden; Andrea Guilliatt; Will Lester; Ian Peake
Journal:  Blood       Date:  2006-09-19       Impact factor: 22.113

6.  Single-cell transcriptional analysis of human endothelial colony-forming cells from patients with low VWF levels.

Authors:  Christopher J Ng; Alice Liu; Sujatha Venkataraman; Katrina J Ashworth; Christopher D Baker; Rebecca O'Rourke; Rajeev Vibhakar; Kenneth L Jones; Jorge Di Paola
Journal:  Blood       Date:  2022-04-07       Impact factor: 22.113

Review 7.  The molecular characterization of von Willebrand disease: good in parts.

Authors:  P D James; D Lillicrap
Journal:  Br J Haematol       Date:  2013-02-14       Impact factor: 6.998

8.  ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease.

Authors:  Paula D James; Nathan T Connell; Barbara Ameer; Jorge Di Paola; Jeroen Eikenboom; Nicolas Giraud; Sandra Haberichter; Vicki Jacobs-Pratt; Barbara Konkle; Claire McLintock; Simon McRae; Robert R Montgomery; James S O'Donnell; Nikole Scappe; Robert Sidonio; Veronica H Flood; Nedaa Husainat; Mohamad A Kalot; Reem A Mustafa
Journal:  Blood Adv       Date:  2021-01-12

9.  Cellular and molecular basis of von Willebrand disease: studies on blood outgrowth endothelial cells.

Authors:  Richard D Starke; Koralia E Paschalaki; Clare E F Dyer; Kimberly J Harrison-Lavoie; Jacqueline A Cutler; Thomas A J McKinnon; Carolyn M Millar; Daniel F Cutler; Mike A Laffan; Anna M Randi
Journal:  Blood       Date:  2013-01-25       Impact factor: 22.113

10.  A role of stochastic phenotype switching in generating mosaic endothelial cell heterogeneity.

Authors:  Lei Yuan; Gary C Chan; David Beeler; Lauren Janes; Katherine C Spokes; Harita Dharaneeswaran; Anahita Mojiri; William J Adams; Tracey Sciuto; Guillermo Garcia-Cardeña; Grietje Molema; Peter M Kang; Nadia Jahroudi; Philip A Marsden; Ann Dvorak; Erzsébet Ravasz Regan; William C Aird
Journal:  Nat Commun       Date:  2016-01-08       Impact factor: 14.919
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.